Bayer (BAYN) 21st Annual Global Farm to Market Conference summary
Event summary combining transcript, slides, and related documents.
21st Annual Global Farm to Market Conference summary
14 May, 2026Strategic framework and execution
Five-year plan focuses on sales growth, margin expansion, and cash generation, targeting over EUR 1 billion in savings across R&D, product supply, and commercial functions.
Innovation pipeline aims to add EUR 3.5 billion to the top line, with major launches planned for 2027–2029 and beyond.
Execution is on track, with EUR 150 million in R&D savings and significant product supply consolidation, including site closures and portfolio pruning.
Margin expansion is supported by ongoing cost discipline and operational adjustments, with a 2026 margin target of 20–22%.
Q1 results confirm guidance for 2026, with top-line growth of 1–4% expected in core business.
Innovation and product launches
Seven biotech traits will launch in the U.S. and six in Brazil over the next five years, accelerating the pace of innovation.
75% of U.S. corn hybrids sold this year are from launches in the past three years, reflecting rapid adoption of new breeding technologies.
Key upcoming products include Preceon short stature corn, Vyconic soybeans, and new crop protection solutions like icafolin and Plenexos.
Vyconic's launch in 2027 will start with limited acreage but is expected to ramp quickly due to broad germplasm availability and strong farmer interest.
Preceon is being scaled thoughtfully, with over 1,100 farmers participating and acreage doubling annually.
Market dynamics and regional trends
U.S. corn and soybean acreage remains stable, with a slight shift from corn to soybeans; no major deviations from USDA expectations.
In Brazil, seed price increases are expected in the low to mid-single digits, driven by innovation and value-based pricing.
Q1 saw strong growth in seeds and traits in Brazil, with soybeans up 9% and corn also performing well.
Uncertainty from global events, such as the Middle East conflict and fertilizer prices, may impact Latin America more significantly in the coming seasons.
Farmers are expected to be cautious with equipment renewal and may rationalize fertilizer use, but demand for seed innovation remains robust.
Latest events from Bayer
- Sales and earnings grew, led by Crop Science, but legal settlements hit cash flow.BAYN
Q1 202612 May 2026 - Sales and earnings rose, led by Crop Science, while legal settlements weighed on cash flow.BAYN
Q1 2026 (Media)12 May 2026 - 2025 guidance met with EUR 45.575B sales; 2026 outlook stable but litigation weighs on cash flow.BAYN
Q4 2025 (Media)4 May 2026 - Shareholders approved all proposals as the company advanced its turnaround and addressed key risks.BAYN
AGM 202628 Apr 2026 - 2025 targets met with resilient sales and EPS; 2026 outlook stable but litigation weighs on cash flow.BAYN
Q4 202527 Apr 2026 - Driving growth through innovation, efficiency, and sustainability across all business divisions.BAYN
Corporate presentation22 Apr 2026 - A $7.25 billion class settlement seeks to resolve U.S. glyphosate claims and provide financial clarity.BAYN
Investor update13 Apr 2026 - Asundexian cut recurrent stroke risk by 26% with no added major bleeding across all subgroups.BAYN
Study result10 Apr 2026 - Innovation-driven growth and sustainability define the group's leadership in health and nutrition.BAYN
Corporate presentation4 Mar 2026